Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest update is out from Cryofocus Medtech (Shanghai) Co. Ltd. Class H ( (HK:6922) ).
Cryofocus Medtech (Shanghai) Co., Ltd. has provided additional details regarding the renewal of its Existing Master Lease Agreement. The new terms will be determined through arm’s length negotiations, ensuring that the rental agreements are competitive with market rates. The company’s finance department will compare rental prices with similar properties and obtain multiple third-party quotations to ensure favorable terms.
More about Cryofocus Medtech (Shanghai) Co. Ltd. Class H
Cryofocus Medtech (Shanghai) Co., Ltd. is a joint stock company based in China, specializing in medical technology solutions.
YTD Price Performance: -2.45%
Average Trading Volume: 14,213
Technical Sentiment Consensus Rating: Buy
For an in-depth examination of 6922 stock, go to TipRanks’ Stock Analysis page.